You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TITE-CRM

Showing 1 - 25 of 131
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial (Decreasing starting times for beginning

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia, in Relapse
  • Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) )
  • Nivolumab starting at day -1
  • (no location specified)
Apr 4, 2022

Pancreatic Carcinoma Non-resectable Trial in Ottawa (CyberKnife® Stereotactic Body Radiotherapy(SBRT)Boost)

Terminated
  • Pancreatic Carcinoma Non-resectable
  • CyberKnife® Stereotactic Body Radiotherapy(SBRT)Boost
  • Ottawa, Ontario, Canada
    The Ottawa Hospital Cancer Centre
Apr 13, 2020

Non Small Cell Lung Cancer Trial in Canada (SBRT)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • SBRT
  • Vancouver, British Columbia, Canada
  • +6 more
Apr 12, 2022

Medication Adherence Trial in Manhasset (5 Behavioral Change Techniques)

Recruiting
  • Medication Adherence
  • 5 Behavioral Change Techniques
  • Manhasset, New York
    Northwell Health
Jul 12, 2023

Lung Cancer Trial in Heidelberg (Stereotactic body radiotherapy (SBRT))

Recruiting
  • Lung Cancer
  • Stereotactic body radiotherapy (SBRT)
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
Nov 2, 2022

Locally Advanced NSCLC Trial in Edinburgh, London, Oxford (Atovaquone Oral Suspension, Standard of care chemo, Standard of care

Recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • Atovaquone Oral Suspension
  • +2 more
  • Edinburgh, United Kingdom
  • +1 more
Dec 21, 2021

Small Cell Lung Cancer Trial in Australia, United States (APG-1252, Paclitaxel)

Terminated
  • Small Cell Lung Cancer
  • Plantation, Florida
  • +7 more
Jul 8, 2022

Non Small Cell Lung Cancer Trial in Newcastle Upon Tyne (Radiotherapy, Olaparib Oral Tablet [Lynparza], AZD1390)

Recruiting
  • Non Small Cell Lung Cancer
  • Radiotherapy
  • +5 more
  • Newcastle Upon Tyne, United Kingdom
    Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust
Sep 20, 2022

Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Ann Arbor, Michigan
    Rogel Cancer Center
Jun 26, 2023

Medication Adherence Trial in New York (5 Behavioral Change Techniques)

Recruiting
  • Medication Adherence
  • 5 Behavioral Change Techniques
  • New York, New York
    Institute of Health System Science
Sep 6, 2022

Insufficient Physical Activity Trial in New York (5 Behavioral Change Techniques)

Recruiting
  • Insufficient Physical Activity
  • 5 Behavioral Change Techniques
  • New York, New York
    Institute of Health System Science
May 17, 2022

Head Neck Cancer Trial in Milwaukee (46 Gy Radiation Therapy, 40 Gy Radiation Therapy, 35 Gy Radiation Therapy)

Not yet recruiting
  • Head and Neck Cancer
  • 46 Gy Radiation Therapy
  • +2 more
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Sep 9, 2022

Glioblastoma Trial in Aarhus (Escalated proton therapy)

Not yet recruiting
  • Glioblastoma
  • Escalated proton therapy
  • Aarhus, Denmark
    Danish Center for Particle Therapy
Mar 2, 2023

Breast Cancer Trial in United States (Rucaparib, Radiotherapy)

Active, not recruiting
  • Breast Cancer
  • Norwalk, Connecticut
  • +7 more
Aug 31, 2022

Resectable Head and Neck Squamous Cell Carcinoma Trial in Milwaukee (42 Gy Radiation Therapy, 39 Gy Radiation Therapy, 32.5 Gy

Suspended
  • Resectable Head and Neck Squamous Cell Carcinoma
  • 42 Gy Radiation Therapy
  • +2 more
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Jan 13, 2023

Advanced Adult Hepatocellular Carcinoma Trial in Chicago, Ann Arbor, Dallas (Cabozantinib)

Recruiting
  • Advanced Adult Hepatocellular Carcinoma
  • Chicago, Illinois
  • +3 more
Aug 15, 2022

Gastrointestinal Cancer Trial in New York, Providence (Cobimetinib, Hydroxychloroquine, Atezolizumab)

Active, not recruiting
  • Gastrointestinal Cancer
  • New York, New York
  • +1 more
Nov 29, 2022

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +4 more
May 5, 2022

Uveal Melanoma Trial in New York, Houston (Selumetinib)

Active, not recruiting
  • Uveal Melanoma
  • New York, New York
  • +2 more
Jun 28, 2022

Head and Neck Tumor Trial in Milwaukee (50 Gy Radiation Therapy, 55 Gy Radiation Therapy, 60 Gy Radiation Therapy)

Recruiting
  • Head and Neck Neoplasm
  • 50 Gy Radiation Therapy
  • +3 more
  • Milwaukee, Wisconsin
    Froedtert & Medical College of Wisconsin
Apr 21, 2022

Prostate Cancer Trial in United States (Niraparib, Leuprolide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Ann Arbor, Michigan
  • +3 more
Oct 18, 2022

Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8

Recruiting
  • Locally Advanced Pancreatic Carcinoma
  • +3 more
  • Biopsy
  • +5 more
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center EDDOP
Nov 30, 2022

Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)

Recruiting
  • Peritoneal Carcinomatosis
  • +7 more
  • PIPAC with Nal-IRI
  • Ghent, East-Flanders, Belgium
    UZ Ghent
Dec 28, 2022

Esophagus Cancer, Esophageal Cancer, Cancer of the Esophagus Trial in Saint Louis (radiation, drug, other, procedure)

Recruiting
  • Esophagus Cancer
  • +2 more
  • Intensity Modulated Radiation Therapy
  • +9 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 6, 2022

Epithelial Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, E7777)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 4, 2022